Northeast Endocrine Metabolic Associates — Philadelphia, Pennsylvania

Northeast Endocrine Metabolic Associates is a clinical research site located in Philadelphia, Pennsylvania, United States 19114.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Northeast Endocrine Metabolic Associates has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Type 2 Diabetes Mellitus, Kidney Disease, Chronic, Diabetes Mellitus, Type 2.

Sponsors: Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Endocrine Metabolic Associates?

Northeast Endocrine Metabolic Associates has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Endocrine Metabolic Associates conducted?

Northeast Endocrine Metabolic Associates has 3 clinical trials on record, with 1 currently active. Their work covers Type 2 Diabetes Mellitus, Kidney Disease, Chronic, Diabetes Mellitus, Type 2.

Is Northeast Endocrine Metabolic Associates accredited by Crixeo Health?

Northeast Endocrine Metabolic Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Endocrine Metabolic Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.